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Corynebacterium striatum: an under recognised cause of
diabetic foot osteomyelitis
G.J. Boyd ∗, N. Weightman, J. Martin
Harrogate and District NHS Foundation Trust, Harrogate,
United Kingdom
Background: In common with other coryneform species,
Corynebacterium striatum colonizes the skin and mucous
membranes of normal hosts, and is one of the more fre-
quent corynebacteria isolated in the clinical laboratory.
However, its clinical signiﬁcance is often unclear as it can
be difﬁcult to distinguish between colonization and infec-
tion. Most reported cases of C. striatum infection are of
endocarditis, pulmonary infection or are associated with
prosthetic devices. We observed a number of cases of dia-
betic foot osteomyelitis in our hospital from which a heavy,
pure growth of C. striatum was isolated from tissue or ﬂuid
samples.
Methods: A review of the medical literature was carried
out and did not suggest C. striatum was a recognised cause
of diabetic foot infection. We identiﬁed all pure cultures of
C. striatum grown in our laboratory from tissue and ﬂuid
samples. We carried out a review of the patients’ medical
notes recording details of past medical history, antimicrobial
history including changes made upon isolation of C. striatum
and the clinical outcomes following appropriate therapy.
Results: Three tissue cultures and one ﬂuid culture of
C. striatum were identiﬁed. The three tissue cultures were
from patients with diabetic foot osteomyelitis. The ﬂuid
sample came from a deep washout of a diabetic foot
ulcer with underlying osteomyelitis, and the growth was
both heavy and pure. The four patients were male, and
had a mean age of 76 years, and all had a diagnosis of
insulin dependent diabetes. They were all were treated
successfully with targeted antimicrobial chemotherapy, and
followed up for at least eight months posttreatment, with
no evidence of disease recurrence.
Conclusion: We report 4 cases of C. striatum osteomyeli-
tis of the foot in patients with diabetes mellitus. We suggest
that where C. striatum is isolated in pure culture from tis-
sue samples from diabetic feet, it should not be discounted
as contaminating ﬂora but considered as a genuine cause of
infection.
doi:10.1016/j.ijid.2010.02.493
77.018
The rising concern of community-acquired methicillin-
resistant Staphylococcus aureus central nervous system
infections: 2 case reports
R. Nog ∗, H. Anyimadu, T. Schliep, O. Alao, V. Sivapalan, C.
Badshah
Columbia University College Of Physicians and Surgeons
afﬁliation at Harlem Hospital Center, New York, NY, USABackground: The increasing incidence of community-
acquired methicillin-resistant Staphylococcus Aureus (CA-
MRSA) central nervous system (CNS) infections in healthcare
settings is concerning and may warrant a reappraisal of cur-
rent treatment guidelines.
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Methods: Case 1: A 64 year old man with no signif-
cant past medical history was admitted with new-onset
eizures. Besides recurrent headaches, there were no associ-
ted symptoms. Physical examination and labs were normal.
T scan of the brain showed a hypodense left parietal
obe mass. However once seizures controlled, he insisted
n early discharge. He was readmitted 12 days later with
ecurrent seizures. Repeat imaging showed a signiﬁcant
ncrease in the size of brain mass. The patient was taken
o OR for emergent excision of the mass which revealed a
rain abscess which grew methicillin-resistant Staphylococ-
us aureus (MRSA) with antibiotic susceptibility consistent
ith a CA-MRSA. The patient was treated postoperatively
ith intravenous vancomycin on which he recovered com-
letely with resolution of the abscess.
Case 2: A 67 year old man was admitted with fever, facial
welling, altered mental status, hypotension and tachypnea
eeding pressers and intubation. He had presented to ER
days earlier with facial swelling and was discharged with
mpression of angioedema. Admission labs showed leukocy-
osis, Brain CT scan revealed cavernous sinus thrombosis and
SF analysis showed leukocytosis, high protein and low glu-
ose. His Blood and CSF cultures grew MRSA and Pulse Field
el Electrophoresis showing Type USA 300. The patient on
reatment had a complicated and prolonged hospital course.
Conclusion: Community-acquired MRSA (CA-MRSA) is now
rmly established as a worldwide, community prevalent
nfection. It’s now increasingly recognized as an organism
ith invasive potential causing an ever-increasing spectrum
f diseases. Only three previous cases of CA-MRSA brain
bscess and CA-MRSAmeningitis with Cavernous sinus throm-
osis have been reported respectively. Both our patient’s
ad a benign initial presentation. In contrast to all fatalities
n previous brain abscess cases, our patient had a complete
ecovery on treatment.
The increasing appearance of life threatening CA-MRSA,
NS infections in healthcareassociated settings and the dif-
culties in readily identifying risk factors warrants measures
o increase awareness and a reappraisal of current emperic
reatment guidelines for Community Acquired Brain Abscess.
oi:10.1016/j.ijid.2010.02.494
7.019
scoring system for severity of disease associated with
ortality for Clostridium difﬁcile associated disease
. Ko ∗, R. Jayasingam, C. Modi, R. Hallit, N. Nguyen, S.
aniel, T. Soleymani, J. Fallon, L. Booth, G. Perez, J. Slim,
. Sensakovic, J. Boghossian
St. Michael’s Medical Center, Newark, NJ, USA
Background: Clostridium difﬁcile associated disease
CDAD) has been an increasing problem and a burden in
ur healthcare system which is estimated to be over a bil-
ion dollars per year in the United States. The increasing
everity of disease has been described in previous literature
ttributed to the BI/NAP1 gene or ribotype 027. There have
een several scoring indices used for CDAD studies such as
odiﬁed Horn’s Index and APACHE II score. We designed a
tudy to stratify by severity of disease over a period of time
nd develop a new scoring system.
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Methods: We reviewed patients with CDAD from January
005 to May 2008 from a 357-bed regional tertiary center,
t. Michael’s Medical Center in Newark, NJ. We analyzed the
ata to arrive at a scoring system based on age, albumin,
reatinine, and WBC. The criterias for the scoring system
ere 0 to 1 mild; 2 to 3 moderate; 4 to 5 severe; 6 to
extremely severe. One point is given for age >60; albu-
in level <2.5mg/dL is given 2 points, albumin between
.5 to 3.5mg/dL is given one point; creatinine level of
2.0mg/dL is given 2 points; creatinine between 1.0 to
.0mg/dL is given 1 point; WBC count of >20,000 cells/mL is
iven 2 points; between 10,000 to 20,000 cells/mL is given
ne point.
Results: The total number of patients with CDAD were
29 from January 2005 through May 2008. The mean age
or 2005, 2006, 2007, and 2008 were 69.1, 64.7, 68.6, and
0.1 respectively. The mean for the lowest albumin lev-
ls were 2.05, 2.04, 2.05, and 2.09mg/dL respectively.
he mean for the highest creatinine levels were 2.25,
.57, 2.58, and 2.24mg/dL. The mean for the highest WBC
ounts were 18,800, 19,400, 18,800, and 21,100 cells/mL.
he recurrence rates were 5.68%, 4.28%, 16.1%, and 8.86%,
espectively. The mortalities for 2006, 2007, and 2008 were
3.25%, 12.75%, and 18.99% respectively (pvalue <0.34). The
ean score for those who were alive were 4.50, 4.73, and
.87 respectively. The mean score for those who expired
ere 5.68, 5.45, and 5.50 respectively which showed high
orrelation with patients with mortality (p-value <0.0001).
Conclusion: There was an increase in mortality for 2008
uggesting virulent strain of C. difﬁcile. The use of the scor-
ng system will identify these patients with likelihood of high
ortality. Therefore clinicians will be able to observe these
atients with closer supervision and treat more aggressively.
oi:10.1016/j.ijid.2010.02.495
7.020
isseminated nocardiosis
.R. Bastidas1, M. Pérez2,∗, A. Piotrostanalzki 3, P. Reyes4,
. Gonzáles5, R. Rada6
Hospital Militar Central, Clinica Universitaria de la Uni-
ersidad de la Sabana, Bogotá, Colombia
Hospital Militar Central, Universidad Militar Nueva
ranada, Bogotá, Colombia
Hospital Militar Central, Universidad Militar Nueva
ranada, Bogotá, Colombia
Hospital Militar Central, Clínica del Country, Bogot{a,
olombia
Hospital Militar Central, Bogotá., Colombia
Hospital Militar Central, Bogotá, Colombia
Background: The Nocardia is described as an infectious
gent of systemic involvement especially in immunocom-
romised patients. From what we wanted to describe the
ase of a patient with type-2 diabetes mellitus developed a
evere systemic infection with fatal outcome.
Methods: We describe the case of a farmer of 62 years
rom the lower Cauca Colombia, who presented a clinical
hat begins with 2 months whitish lesions in the mouth,
ssociated with persistent fever and gradual onset of cough,
emoptysis, dyspnea, cyanosis and generalized pustule skin
c
dternational Congress on Infectious Diseases (ICID) Abstracts
esions with budding tree display and cavitary lesions in lung
nd liver abscess only, with no echocardiographic vegeta-
ions and negative blood cultures. In skin culture displayed
lamentous gram-positive bacteria compatible with Nocar-
ia.
Results: The patient has an unfavorable clinical course
ith eventual development of multiple organ failure and
eath.
Conclusion: Nocardiosis should be taken into account as
n etiologic agent in immunocompromised patients from
ural areas with systemic manifestations and progressive
linical deterioration.
oi:10.1016/j.ijid.2010.02.496
7.021
ffectiveness of linezolid versus vancomycin treatment
or MRSA skin and soft tissue infections
. Yim ∗, J. Steingisser, R. Kan, A. Nshala, R. Larson
Dartmouth College, Hanover, NH, USA
Background: Methicillin-resistant Staphylococcus aureus
MRSA) infections of skin and soft tissues are an increas-
ng concern in hospital and community settings. Whether
ewer agents like linezolid offer efﬁcacy, safety or cost
dvantages over traditional ﬁrst line treatment with van-
omycin is not known. We conducted a systematic review
nd meta-analysis to assess the safety and efﬁcacy of line-
olid compared to vancomycin in hospitalized patients with
resumed MRSA infections of skin or soft tissue.
Methods: In October 2009, we searched MEDLINE (1950-
009), Web of Science (1900- 2009), both the Cochrane
atabase of Systematic Reviews and CENTRAL (Issue 4,
009), ClinicalTrials.gov, relevant conference proceedings
nd reference lists using no limits. We selected randomized
ontrolled trials comparing linezolid (intravenous or oral)
ersus vancomycin (intravenous) in non-surgical hospitalized
atients with MRSA-infected or suspected skin or soft tissue
nfections who were followed for a minimum of 7 days. Two
ndependent reviewers extracted data from each qualify-
ng report using a standard data collection form. We used
ochrane Collaboration’s risk of bias tool to assess method-
logical quality and data was summarized in RevMan using
andom effects models.
Results: Of 455 reports identiﬁed, 7 studies qualiﬁed
or inclusion. Linezolid was favored over vancomycin for
linical cure rate (RR 0.79; 95% CI 0.67, 0.94; P = 0.007)
nd microbiological eradication rate (RR 0.80; 95% CI 0.62,
.04; P = 0.10). Analysis of adverse events revealed no dif-
erence between the two agents (RR 0.98; 95% CI 0.76, 1.27;
= 0.90). Results for length of stay were inconclusive.
Conclusion: Our results suggest that linezolid is more
ffective than vancomycin for achieving clinical cure in
ospitalized patients with MRSA skin and soft tissue infec-
ions while adverse events are no different. However, other
mportant beneﬁts and tradeoffs such as length of stay,
esistance, and cost would be important to explore before
hanging current practice.
oi:10.1016/j.ijid.2010.02.497
